Tivic Health Systems, Inc. Receives Nasdaq Notification of Non-Compliance with Minimum Bid Price Requirement
Key Points:
- Tivic Health Systems, Inc. (“the Company”) has received a formal notification from the Nasdaq Stock Market LLC regarding its failure to comply with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
- The closing bid price for Tivic’s common stock (trading symbol: TIVC) has been below \$1.00 per share for at least 30 consecutive business days, triggering this non-compliance notice under Nasdaq Listing Rule 5550(a)(2).
- This notification does not result in immediate delisting; Tivic’s listing status on the Nasdaq Capital Market remains fully effective at this time.
Details and Timeline:
- Date of Notice: March 19, 2026
- Compliance Period: Tivic now has a period of 180 calendar days (until September 15, 2026) to regain compliance with the minimum bid price requirement.
- If at any time before September 15, 2026, the closing bid price of Tivic’s common stock is at or above \$1.00 per share for at least 10 consecutive business days, Nasdaq will notify the Company that it has regained compliance, and the issue will be resolved.
- If the Company fails to regain compliance by the end of this period, Nasdaq may grant a second 180-day grace period, provided Tivic meets all other listing requirements except for the minimum bid price and notifies Nasdaq of its intent to cure the deficiency.
- If compliance is not achieved, Tivic’s common stock will be subject to delisting, though the Company would have the right to appeal that decision before a Nasdaq hearings panel.
Shareholder Impact and Potential Price Sensitivity:
- This notice is material and price-sensitive because it signals potential risks to Tivic’s continued listing on Nasdaq. If Tivic is ultimately delisted, liquidity and investor confidence could be adversely affected.
- The Company is actively monitoring its stock price and is considering options to resolve the deficiency, but there can be no assurance that compliance will be regained within the allowed period or that extensions will be granted.
- Failure to maintain Nasdaq listing may impact the Company’s ability to raise capital and could negatively affect share value and trading volume.
Other Relevant Information:
- Tivic Health Systems, Inc. continues to be classified as an emerging growth company.
- The Company has not elected to use the extended transition period for complying with any new or revised financial accounting standards.
- Chief Financial Officer Lisa Wolf signed the Form 8-K report on March 20, 2026.
- Common Stock details: par value \$0.0001 per share, trading symbol: TIVC, exchange: NASDAQ.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial advisors before making any investment decisions. The information provided is based on the latest SEC filings and may be subject to change. Tivic Health Systems, Inc. has not regained compliance as of the date of this report, and future outcomes are uncertain.
View Tivic Health Systems, Inc. Historical chart here
